Point-of-care Ultrasound Abnormalities in Eclampsia

Recruiting N/A Interventional Study
Eclampsia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
70 (estimated)
Sponsor
University of Cape Town · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Preeclampsia (PE) and eclampsia remain leading causes of maternal morbidity and mortality, in both high-, low-and-middle-income countries. Preeclampsia is a complex, multisystem disease which, in its severe form, affects the cardiovascular, renal, hepatic, neurological and haematological systems. Given the complexity of the disease, anaesthesia management for caesarean section in these patients re…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of preeclampsia following ACOG definition with new onset of tonic-clonic seizures. Exclusion Criteria: * Chronic pulmonary disease * Collagen disorders * HIV infection if CD4 count \<200 cells/ mm3 * Chronic renal or hepatic disease * Urinary tract infection * Seps…
Contacts

Robert Dyer, MBChB, PhD

+27214045001

robert.dyer@uct.ac.za

CONTACT

Margot Flint, PhD

+27214045144

margot.flint@uct.ac.za

CONTACT